Citi Upgrades Arcturus Therapeutics (ARCT) to Buy
Citi analyst Yigal Nochomovitz upgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

